We thank Dr. Özdemir for his interest in our article and for his thoughtful comments regarding our study on peach sublingual immunotherapy (Prup3 SLIT) in patients with lipid transfer protein (LTP) syndrome. We appreciate the opportunity to clarify several methodological aspects of our study.